Literature DB >> 29651619

Silk fibroin-based woven endovascular prosthesis with heparin surface modification.

Zekun Liu1, Gang Li2, Zhaozhu Zheng1, Yuling Li3, Yifan Han4, David L Kaplan1,5, Xiaoqin Wang6,7.   

Abstract

A novel seamless silk fibroin-based endovascular prosthesis (SFEPs) with bifurcated woven structure and anticoagulant function for the improvement of patency is described. The SFEPs were prepared from silk fibroin (SF) and polyester filaments using an installed weaving machine. The production processing parameters were optimized using orthogonal design methods. The inner surface of SFEPs was modified with polyethylenimine (PEI) and EDC/NHS-activated low-molecular-weight heparin (LMWH) to enhance anticoagulant function. The surface morphology and mechanical properties of the SFEPs were evaluated according to standard protocols. The thickness of modified SFEPs was lower than 0.085 ± 0.004 mm and water permeability was lower than 5.19 ± 0.30 mL/(cm2 × min). The results of mechanical properties showed that the diametral tensile strength and burst strength reached 61.6 ± 1.8 and 23.7 ± 2.2 MPa, respectively. Automatic coagulometer and energy-dispersive X-ray (EDX) confirmed LMWH immobilization on the surface of the SFEPs and the blood compatibility was improved with the heparin modification with PEI polymerization. In conclusion, the new prosthesis has potential applications in the blood vessel repairs where minimal thickness but superior mechanical strength and biocompatibility are important.

Entities:  

Mesh:

Substances:

Year:  2018        PMID: 29651619     DOI: 10.1007/s10856-018-6055-3

Source DB:  PubMed          Journal:  J Mater Sci Mater Med        ISSN: 0957-4530            Impact factor:   3.896


  21 in total

1.  The mathematical model for evaluating fatigue resistance of SG tubular fabric: relationship between textile parameters and fatigue performance.

Authors:  Huijing Zhao; Lu Wang; Yuling Li; Xiaoyan Liu; Martin W King
Journal:  J Biomater Appl       Date:  2008-12-12       Impact factor: 2.646

2.  Highly ductile multilayered films by layer-by-layer assembly of oppositely charged polyurethanes for biomedical applications.

Authors:  Paul Podsiadlo; Ming Qin; Meghan Cuddihy; Jian Zhu; Kevin Critchley; Eugene Kheng; Amit K Kaushik; Ying Qi; Hyoung-Sug Kim; Si-Tae Noh; Ellen M Arruda; Anthony M Waas; Nicholas A Kotov
Journal:  Langmuir       Date:  2009-12-15       Impact factor: 3.882

3.  Self-expanding endovascular prosthesis: an experimental study.

Authors:  H Rousseau; J Puel; F Joffre; U Sigwart; C Duboucher; C Imbert; C Knight; L Kropf; H Wallsten
Journal:  Radiology       Date:  1987-09       Impact factor: 11.105

4.  The enhancement of VEGF-mediated angiogenesis by polycaprolactone scaffolds with surface cross-linked heparin.

Authors:  Shivani Singh; Benjamin M Wu; James C Y Dunn
Journal:  Biomaterials       Date:  2010-12-13       Impact factor: 12.479

Review 5.  Blood vessel replacement: 50 years of development and tissue engineering paradigms in vascular surgery.

Authors:  J Chlupáč; E Filová; L Bačáková
Journal:  Physiol Res       Date:  2009       Impact factor: 1.881

6.  Long-term patency of small-diameter vascular graft made from fibroin, a silk-based biodegradable material.

Authors:  Soichiro Enomoto; Makoto Sumi; Kan Kajimoto; Yasumoto Nakazawa; Rui Takahashi; Chiyuki Takabayashi; Tetsuo Asakura; Masataka Sata
Journal:  J Vasc Surg       Date:  2009-12-02       Impact factor: 4.268

7.  Treatment of complex aneurysmal disease with fenestrated and branched stent grafts.

Authors:  C D Bicknell; N J W Cheshire; C V Riga; P Bourke; J H N Wolfe; R G J Gibbs; M P Jenkins; M Hamady
Journal:  Eur J Vasc Endovasc Surg       Date:  2008-12-01       Impact factor: 7.069

8.  The effect of stromal cell-derived factor-1α/heparin coating of biodegradable vascular grafts on the recruitment of both endothelial and smooth muscle progenitor cells for accelerated regeneration.

Authors:  Jian Yu; Aijun Wang; Zhenyu Tang; Jeffrey Henry; Benjamin Li-Ping Lee; Yiqian Zhu; Failei Yuan; Fengping Huang; Song Li
Journal:  Biomaterials       Date:  2012-08-11       Impact factor: 12.479

9.  Preparing silk fibroin nanofibers through electrospinning: further heparin immobilization toward hemocompatibility improvement.

Authors:  Marília Cestari; Vinícius Muller; Jean Henrique da Silva Rodrigues; Celso V Nakamura; Adley F Rubira; Edvani C Muniz
Journal:  Biomacromolecules       Date:  2014-04-11       Impact factor: 6.988

10.  In vitro and in vivo evaluation of the safety and stability of the TAXUS Paclitaxel-Eluting Coronary Stent.

Authors:  Mark Boden; Robert Richard; Marlene C Schwarz; Steve Kangas; Barbara Huibregtse; James J Barry
Journal:  J Mater Sci Mater Med       Date:  2009-03-04       Impact factor: 3.896

View more
  2 in total

1.  Low-Molecular-Weight Heparin-Functionalized Chitosan-Chondroitin Sulfate Hydrogels for Controlled Release of TGF-β3 and in vitro Neocartilage Formation.

Authors:  You-Rong Chen; Zhu-Xing Zhou; Ji-Ying Zhang; Fu-Zhen Yuan; Bing-Bing Xu; Jian Guan; Chao Han; Dong Jiang; Yan-Yu Yang; Jia-Kuo Yu
Journal:  Front Chem       Date:  2019-11-01       Impact factor: 5.221

2.  Anti-Coagulant and Antimicrobial Recombinant Heparin-Binding Major Ampullate Spidroin 2 (MaSp2) Silk Protein.

Authors:  Pranothi Mulinti; Dorina Diekjürgen; Kristen Kurtzeborn; Narayanaganesh Balasubramanian; Shane J Stafslien; David W Grainger; Amanda E Brooks
Journal:  Bioengineering (Basel)       Date:  2022-01-19
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.